4225 EXECUTIVE SQUARE, LA JOLLA, CA
Investor Presentation
Reports Second Quarter 2026 Financial Results and Recent Corporate Updates
Zura Bio Limited Approves Amended 2023 Equity Incentive Plan
Director Resignation - Someit Sidhu Steps Down from Zura Bio Board
Reports First Quarter 2026 Financial Results and Recent Corporate Updates
Annual Report to Security Holders
CFO Departure - Eric Hyllengren Separated from Zura Bio Limited
Q2
Q1
FY 2025
Q3
FY 2024
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(5)
Effectiveness Notice
Amended Registration Statement for Securities Offered under a Shelf Registration
Additional Proxy Materials
Definitive Proxy Statement
PRE 14A
Notice of Proposed Sale of Securities
Initial Statement of Beneficial Ownership
Statement of Changes in Beneficial Ownership
Submission Upload
Correspondence